List of 61 Bipolar Disorder Medications Compared - Drugs.com
2024年2月19日 · Compare risks and benefits of common medications used for Bipolar Disorder. Find the most popular drugs, view ratings and user reviews.
What’s Next for Bipolar Treatment? - WebMD
2022年1月25日 · New treatments for bipolar disorder are on the horizon. Here’s a look at some of the latest advances, as well as experimental therapies.
Caplyta Now Approved for Bipolar Depression | Psychiatric News
2022年1月28日 · With the FDA’s expanded indication, Caplyta (lumateperone) becomes just the second medication for both bipolar I and bipolar II depression. It is also the first approved for …
FDA Approves New Treatment for Bipolar Depression
2021年12月21日 · Caplyta, an atypical antipsychotic from biopharmaceutical company Intra-Cellular Therapies, is the only drug approved by the FDA for the treatment of depressive …
Current and Emerging Therapies for Bipolar Disorder - U.S.
2024年5月14日 · Current pharmacotherapies, many of which were serendipitously discovered, sufficiently target aberrant neurotransmission but yield inadequate outcomes and cause …
Top 10 Repurposed Drug Candidates for Bipolar Disorder …
2024年1月25日 · The study on network-based drug repurposing presents a pioneering approach in the search for new treatments for Bipolar Disorder (BD), addressing the critical need for …
US FDA approves Vanda's drug for treatment of bipolar disorder
2024年4月2日 · The U.S. FDA approved Vanda Pharmaceuticals' drug to treat manic and mixed episodes associated with a type of bipolar disorder, the company said on Tuesday, marking …
Guide to New Bipolar Medications - NeuroLaunch
2023年10月13日 · Recent advances in bipolar medications have been driven by a deeper understanding of the neurobiological mechanisms underlying the disorder. Researchers have …
FDA Approves Lumateperone for the Treatment of Bipolar Depression
2021年12月20日 · The FDA has approved lumateperone (Caplyta; Intra-Cellular Therapies) for the treatment of depressive episodes associated with bipolar I or II disorder in adults as …
FDA Approved New Bipolar Medication 2024 - ClinicSpots
2024年5月8日 · This new approval represents a hopeful advancement for those suffering from Bipolar I disorder, potentially improving patient outcomes during acute manic or mixed …